<DOC>
	<DOCNO>NCT00178542</DOCNO>
	<brief_summary>The primary objective study describe characteristic trend thrombin generation ( TG ) thromboelastography ( TEG ) 4 time point menstrual cycle .</brief_summary>
	<brief_title>Change Thrombin Generation Potential Thromboelastography During Menstrual Cycle</brief_title>
	<detailed_description>We propose TG TEG sensitive traditional coagulation assay detect physiologic variation hemostasis , fibrinolysis , platelet activation throughout menstrual cycle . We expect TG TEG well discriminate patient vWD traditional coagulation study menstrual cycle . In study plan measure TG TEG healthy woman woman von Willebrand 's disorder four phase menstrual cycle . We compare specific measurement endogenous thrombin generation potential TG fibrinolysis platelet activation TEG standard measure coagulation , fibrinolysis , platelet activation marker menstrual cycle .</detailed_description>
	<mesh_term>Von Willebrand Diseases</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<criteria>Females reproductive age regular menstrual cycle diagnosis von Willebrand disease accord International Society Thrombosis Hemostasis diagnostic criterion . Females pregnant , history endocrinopathy hormone imbalance History hysterectomy bilateral oophorectomy History ovarian uterine cancer Use intrauterine device Use antifibrinolytic therapy , hemostatic agent , antiplatelet agent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>von Willebrand Disease</keyword>
	<keyword>Healthy Women Women von Willebrand Disease</keyword>
</DOC>